Dronabinol (Respirerx Pharmaceuticals)

N/A

Report date: 2025/12/12 15:30:16

Base Information

Drug NameDronabinol (Respirerx Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid receptor agonists
TargetsCannabinoid receptor
Therapy Area/IndicationsSleep Apnea, Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesRespirerx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesRespirerx Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsSleep Apnea, Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A